Evidence map›Paper›PMID 30956516›Full record

ArticlePolymers for advanced technologies2019

Insulin immobilized PCL-cellulose acetate micro-nanostructured fibrous scaffolds for tendon tissue engineering.

Daisy M Ramos, Sama Abdulmalik, Michael R Arul, Swetha Rudraiah, Cato T Laurencin, Augustus D Mazzocca, Sangamesh G Kumbar

Open access · greenAbstract read
In one paragraph

Article in Polymers for advanced technologies, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Biomimetic Scaffolds for Tendon Tissue Regeneration.Biomimetics (Basel, Switzerland) · 2023
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. [The research progress of bionic scaffolds in ligament tissue engineering].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2021
    Review
  13. Review
  14. Article
  15. Review
  16. Growth Factor Roles in Soft Tissue Physiology and Pathophysiology.Advances in experimental medicine and biology · 2021
    Article
  17. Article
  18. Review
  19. Micro-Nanostructured Polymeric Scaffolds for Bone Tissue Engineering.International journal of high speed electronics
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Daisy M RamosDepartment of Materials Science and Engineering, University of Connecticut, Storrs, Connecticut.
Sama AbdulmalikDepartment of Orthopaedic Surgery, University of Connecticut Health, Farmington, Connecticut.
Michael R ArulDepartment of Orthopaedic Surgery, University of Connecticut Health, Farmington, Connecticut.
Swetha RudraiahDepartment of Pharmaceutical Sciences, University of Saint Joseph, Hartford, Connecticut.
Cato T LaurencinDepartment of Materials Science and Engineering, University of Connecticut, Storrs, Connecticut.
Augustus D MazzoccaDepartment of Orthopaedic Surgery, University of Connecticut Health, Farmington, Connecticut.
Sangamesh G KumbarDepartment of Materials Science and Engineering, University of Connecticut, Storrs, Connecticut.ORCID 0000-0001-7672-4783
University of Connecticut · USUConn Health · USUniversity of Saint Joseph · US

Funding

Biodegradable Matrices for Bone HealingR01EB020640 · NIBIB · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KUMBAR, SANGAMESH GURAPPA, YU, XIAOJUN · 2017 to 2020
$1.6M
NIBIB NIH HHS R01 EB020640
6 · The paper itself

Abstract

Use of growth factors as biochemical molecules to elicit cellular differentiation is a common strategy in tissue engineering. However, limitations associated with growth factors, such as short half-life, high effective physiological doses, and high costs, have prompted the search for growth factor alternatives, such as growth factor mimics and other proteins. This work explores the use of insulin protein as a biochemical factor to aid in tendon healing and differentiation of cells on a biomimetic electrospun micro-nanostructured scaffold. Dose response studies were conducted using human mesenchymal stem cells (MSCs) in basal media supplemented with varied insulin concentrations. A dose of 100-ng/mL insulin showed increased expression of tendon markers. Synthetic-natural blends of various ratios of polycaprolactone (PCL) and cellulose acetate (CA) were used to fabricate micro-nanofibers to balance physicochemical properties of the scaffolds in terms of mechanical strength, hydrophilicity, and insulin delivery. A 75:25 ratio of PCL:CA was found to be optimal in promoting cellular attachment and insulin immobilization. Insulin insulin deliveryimmobilized fiber matrices also showed increased expression of tendon phenotypic markers by MSCs similar to findings with insulin supplemented media, indicating preservation of insulin bioactivity. Insulin functionalized scaffolds may have potential applications in tendon healing and regeneration.

Indexed as

cellulose acetategrowth factor alternativeinsulinmicro-nanofiberspolycaprolactonetendontissue engineering

Identifiers

PMID30956516
PMCPMC6448803
OpenAlexW2914957627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.